Free Newsletter
Court slashes talc verdict to $2.1 billion
A Missouri appeals court has nearly slashed in half a $4.69 billion verdict against Johnson & Johnson in a talcum powder lawsuit after ruling a St. Louis judge did not have jurisdiction to hear claims from out-of-state plaintiffs.
Court considers $4.69 billion verdict in talcum-powder case
A Missouri appeals court held rare in-person oral arguments Friday in a case that resulted in a $4.69 billion verdict for a group of women who claimed they contracted ovarian cancer from using Johnson & Johnson talcum powder. The case was originally set for hearing on April 7, but after most in-person hearings were canceled […]
J&J slashes outlook, races to develop coronavirus vaccine
Johnson & Johnson, anticipating significant impact from the COVID-19 pandemic, slashed its 2020 sales forecast by billions of dollars and also cut its profit expectations. It’s one of the first major U.S. corporations to report first-quarter earnings and likely a harbinger of things to come as the outbreak disrupts the global economy. The world’s biggest […]
Johnson & Johnson posts higher sales, big 4Q profit jump
Higher prescription drug sales helped push Johnson & Johnson’s fourth-quarter profit up by 32 percent. The world’s biggest maker of health care products reported net income of $4.01 billion, or $1.50 per share. That’s up from $3.04 billion, or $1.12, a year earlier. Adjusted earnings came to $1.88 per share, matching the expectations of industry […]
Johnson & Johnson posts higher sales, big 4Q profit jump
Higher prescription drug sales helped push Johnson & Johnson’s fourth-quarter profit up by 32 percent. The world’s biggest maker of health care products reported net income of $4.01 billion, or $1.50 per share. That’s up from $3.04 billion, or $1.12, a year earlier. Adjusted earnings came to $1.88 per share, matching the expectations of industry […]
U.S.-led study finds no strong sign linking baby powder and cancer
U.S. government-led research found no strong evidence linking baby powder with ovarian cancer in the largest analysis to look at the question. The findings were called “overall reassuring” in an editorial published Tuesday with the study in the Journal of the American Medical Association. The analysis involving 250,000 women isn’t definitive but more conclusive research probably isn[...]
Jurors side with defense in talcum-powder case
Following a three-week trial, a St. Louis jury on Dec. 20 rejected claims that a woman’s ovarian cancer was caused by Johnson & Johnson-brand talcum powder. The plaintiff, Vickie Forrest, suffered from a rare form of ovarian cancer that she alleged was linked to her use of the company’s baby powder. In its 9-3 verdict, […]
Missouri to get $2.4 million following mesh settlement
Johnson & Johnson has agreed to pay $116.9 million to settle a series of lawsuits brought against it by several state attorneys general alleging the company deceptively marketed transvaginal-mesh products. Missouri Attorney General Eric Schmitt announced the settlement Oct. 17, noting that Missouri will receive more than $2.4 million of that overall settlement. Missouri was […]
Eastern District ruling reverses $110M verdict in talcum powder case
The Court of Appeals Eastern District ruled Oct. 15 that a St. Louis judge should not have heard a Virginia woman’s claim against Johnson & Johnson, throwing out a $110.5 million verdict in her favor. The verdict was the second-largest plaintiffs’ win of 2017, as tracked by Missouri Lawyers Media. But recent court rulings doomed […]
Missouri appeals court overturns $110 million talc verdict
A Missouri appeals court has overturned a $110 million verdict in a case alleging that Johnson & Johnson products containing talcum powder caused a Virginia woman’s ovarian cancer. The appeals court ruling Tuesday reversed a 2017 judgment on behalf of Lois Slemp. She is among many women whose lawsuits have claimed that Johnson & Johnson’s […]
Higher 3Q profit, improved outlook for Johnson & Johnson
Johnson & Johnson’s third-quarter profit jumped 23 percent, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world’s biggest maker of health care products also raised its financial forecast for the year, and its shares jumped more than 2 […]
Higher 3Q profit, improved outlook for Johnson & Johnson
Johnson & Johnson’s third-quarter profit jumped 23 percent, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world’s biggest maker of health care products also raised its financial forecast for the year, and its shares jumped more than 2 […]
Latest Opinion Digests
- Criminal Law: Child Abuse-Sufficiency Of Evidence-Closing Argument
- Civil Rights: Religious Freedom-RLUIPA-Res Judicata
- Civil Practice: Res Judicata-Stop Work Order
- Immigration: Drug Conviction-Removability-Overbreadth of State Offense
- Civil Practice: Asset Forfeiture-Sanctions
- Civil Rights: Due Process-Failure to State Claim
- Probate : Revocable Trust – Amendment – Reformation
- Employer – Employee : Unpaid Commissions – At-Will Status
- Criminal Law : Post-Conviction Relief – Effectiveness Of Counsel – Conflict Of Interest
- Appellate Practice : Jurisdiction – Final Judgment
- Domestic Relations : Parenting Plan – Child Support
- Criminal Law : Post-Conviction Relief – Guilty Plea – Sentence Advice
Top stories
- Missouri Lawyers Media’s legal coverage commended
- Cole County prosecutor loses third Sunshine Law appeal
- Supreme Court weighs lagging symptoms in work comp case
- New accommodation rights for pregnant workers offer broad protections
- Clark named as next Eastern District chief judge
- Russell reflects on change as women take charge of Missouri’s legal system
- NCAA scores positive gender equity review from St. Louis firm
- Big improvements for Missouri bar takers | List of bar passers
